Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.Nature communications · 2026-06-24Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSDClinicalTrials.gov · 2026-05-26Human brain changes after first psilocybin useNature Communications · 2026-05-05The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.The British journal of psychiatry: the journal of mental science · 2026-05-01Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-18Psilocybin for Treatment-Resistant OCD: A Randomized Controlled TrialPsyArXiv · 2026-01-15Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot StudyJournal of Complementary and Alternative Medical Research · 2025-12-16Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].Neuropharmacology · 2025-12-01Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.ACS chemical neuroscience · 2025-11-19Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.Neuropharmacology · 2025-11-15Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.Translational psychiatry · 2025-11-13Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-02Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.Nature communications · 2025-09-30Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.PLoS medicine · 2025-09-01A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-15Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-015-HT receptors: Pharmacology and functional selectivity.Pharmacological reviews · 2025-07-01The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.ACS pharmacology & translational science · 2025-06-13Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.Journal of racial and ethnic health disparities · 2025-06-01Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Neuroscience and biobehavioral reviews · 2025-05-01The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex.Molecular brain · 2025-03-18Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)Journal of Pharmacology and Experimental Therapeutics · 2025-03-01Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.The British journal of psychiatry: the journal of mental science · 2025-03-01A qualitative analysis of the psychedelic mushroom come-up and come-down.Npj mental health research · 2025-02-07From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).Scientific reports · 2025-01-29Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2025-01-01Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.medRxiv: the preprint server for health sciences · 2025-01-01Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.The Journal of pharmacology and experimental therapeutics · 2025-01-01An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.Neuroscience applied · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.Frontiers in psychiatry · 2025-01-01Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.Frontiers in psychiatry · 2025-01-01High hopes? Precision psychedelic addiction medicine.Frontiers in psychiatry · 2025-01-01Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human PrimatesProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-25Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological PotentialsInternational Journal for Research in Applied Science and Engineering Technology · 2024-11-17Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.Journal of psychopharmacology (Oxford, England) · 2024-10-01Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.Scientific reports · 2024-07-17Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Molecular psychiatry · 2024-07-01Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-07Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.Psychological medicine · 2024-06-01Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.JAMA psychiatry · 2024-06-01Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.iScience · 2024-05-17Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.Journal of affective disorders · 2024-05-15The Classical Psychedelic Psilocybin Mitigates Oxycodone WithdrawalJournal of Pharmacology and Experimental Therapeutics · 2024-05-13Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-13Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.Journal of medicinal chemistry · 2024-05-09Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024-05-01The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-22Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortexAuthorea Preprints · 2024-04-22Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.Brain sciences · 2024-03-31Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-23Effects of DMT on mental health outcomes in healthy volunteers.Scientific reports · 2024-02-07Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Neuroscience applied · 2024-01-01Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2024-01-01Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences.Frontiers in psychology · 2024-01-01Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-26Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-26An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05Neuroimaging in psychedelic drug development: past, present, and future.Molecular psychiatry · 2023-09-01HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.Journal of pain and symptom management · 2023-09-01Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.Scientific reports · 2023-08-22Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-20A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.Journal of psychopharmacology (Oxford, England) · 2023-07-01Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive EffectsJournal of Pharmacology and Experimental Therapeutics · 2023-05-17Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2023-01-01A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteersNeuroscience Applied · 2023-01-01Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.Applied and environmental microbiology · 2022-12-20Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trialPsyArXiv · 2022-10-19Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-07A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30Psilocybin-induced takotsubo cardiomyopathy.BMJ case reports · 2022-05-17A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-05-10Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2022-01-01Acute change in functional brain entropy following psilocybin administration in healthy volunteersNeuroscience Applied · 2022-01-01Psychedelics and health behaviour change.Journal of psychopharmacology (Oxford, England) · 2022-01-01Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of psychopharmacology (Oxford, England) · 2022-01-01Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.Journal of psychopharmacology (Oxford, England) · 2022-01-01Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in pharmacology · 2022-01-01A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsEuropean Neuropsychopharmacology · 2021-12-01P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-12-01P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-12-01Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyPsychopharmacology · 2021-11-03Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-09-01Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-07Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.Journal of psychopharmacology (Oxford, England) · 2021-04-01Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reportsPsyArXiv · 2021-02-24Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.Frontiers in psychiatry · 2021-01-01Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-01The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01Psilocybin: from ancient magic to modern medicine.The Journal of antibiotics · 2020-10-01Psilocybin occasioned mystical-type experiences.Human psychopharmacology · 2020-09-01Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-07-14Psychedelic Psychiatry's Brave New World.Cell · 2020-04-02A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines.Human psychopharmacology · 2020-01-01P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-12-01Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Cessation and reduction in alcohol consumption and misuse after psychedelic use.Journal of psychopharmacology (Oxford, England) · 2019-09-01Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.Experimental and clinical psychopharmacology · 2019-06-01Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-06-01Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.Frontiers in psychiatry · 2019-01-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).ACS chemical neuroscience · 2018-10-17Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).ACS chemical neuroscience · 2018-10-17Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance ReportsFrontiers in Neuroscience · 2018-01-21d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.Progress in brain research · 2018-01-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.Persoonia · 2015-06-01The Heffter Research Institute: past and hopeful future.Journal of psychoactive drugs · 2014-01-01Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia bulletin · 2013-11-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.Human psychopharmacology · 2012-07-01Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-04-01Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British journal of psychiatry: the journal of mental science · 2012-03-01Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07Iconography in Bradshaw rock art: breaking the circularity.Clinical & experimental optometry · 2011-09-01P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-07Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOIPsychopharmacology · 2008-07-04Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.Psychopharmacology · 2006-07-05Patterns of simultaneous polysubstance use in drug using university students.Human psychopharmacology · 2006-06-01Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A ReceptorThe FASEB Journal · 2006-03-01Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.Journal of medicinal chemistry · 2000-11-30Hallucinogenic drugs attenuate the subjective response to alcohol in humans.Human psychopharmacology · 2000-10-01Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.Journal of medicinal chemistry · 1999-10-07ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin.ChemInform · 1999-08-17Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of PsilocinSynthesis · 1999-06-01The genus psilocybeJournal of Ethnopharmacology · 1984-05-01Sequelae of a 'magic mushroom banquet'.Postgraduate medical journal · 1981-08-31ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPYChemischer Informationsdienst · 1981-07-14Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopyJournal of Medicinal Chemistry · 1981-02-01Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications.The British journal of psychiatry: the journal of mental science · 1978-06-01Time contraction and psychomotor performance produced by "Psilocybin".Nature · 1966-01-22THE IN VITRO INHIBITORY EFFECT OF PSILOCYBIN AND RELATED COMPOUNDS OF HUMAN CHOLINESTERASES.Psychopharmacologia · 1963-05-15An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809).The Journal of pharmacology and experimental therapeutics · 1963-04-01AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)The Journal of Pharmacology and Experimental Therapeutics · 1963-03-31Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight.The Journal of pharmacology and experimental therapeutics · 1962-04-01CLINICAL OBSERVATIONS OF SIMULTANEOUS HALLUCINOGEN ADMINISTRATION IN IDENTICAL TWINSAmerican Journal of Psychiatry · 1962-03-01The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.The Journal of pharmacology and experimental therapeutics · 1960-10-01Some observations on psilocybin, a new hallucinogen, in volunteer subjects.Comprehensive psychiatry · 1960-02-01